Upstream Bio, Inc. (UPB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $152.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Upstream Bio, Inc. (UPB) Competitors
The companies most similar to Upstream Bio are Palisade Bio (PALI), Sutro Biopharma (STRO) and Invivyd (IVVD). By market cap, Upstream Bio ranks 9th of the 13 companies on this page; Precision BioSciences (DTIL) is the largest at $288.76M.
Peer Comparison
UPB's revenue growth of -42.2% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Upstream Bio (UPB) | $152.38M | N/A | 41.0x | 0.0% | N/A | -42.2% | 0.00% |
| Palisade Bio Inc (PALI) | $201.01M | N/A | 436.8x | 0.0% | N/A | 0.0% | 0.00% |
| Sutro Biopharma (STRO) | $163.03M | N/A | 3.4x | 0.0% | N/A | -6.1% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| SAB Biotherapeutics Inc (SABS) | $266.66M | N/A | N/A | 0.0% | N/A | -62.4% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Innate Pharma (IPHA) | $154.15M | N/A | 17.6x | 0.0% | 489.8% | 16.5% | 0.00% |
| Korro Bio, Inc. (KRRO) | $186.81M | N/A | 175.8x | 0.0% | -82.8% | -43.1% | 0.00% |
| Bright Minds Biosciences Inc (DRUG) | $227.96M | N/A | N/A | 0.0% | -11.2% | 0.0% | 0.00% |
| Anixa Biosciences Inc (ANIX) | $91.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Precision BioSciences Inc (DTIL) | $288.76M | N/A | 4.4x | -85.6% | -38.3% | 37272.0% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PDS Biotechnology Corp (PDSB) | $107.07M | N/A | N/A | 0.0% | -149.8% | 0.0% | 0.00% |
| Peer median | $167.30M | N/A | 11.0x | 0.0% | -38.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Upstream Bio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Palisade Bio Inc (PALI) | Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. | PALI competitors |
| Sutro Biopharma (STRO) | Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. | STRO competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| SAB Biotherapeutics Inc (SABS) | SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. | SABS competitors |
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| Innate Pharma (IPHA) | Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France... | |
| Korro Bio, Inc. (KRRO) | Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare... | KRRO competitors |
| Bright Minds Biosciences Inc (DRUG) | Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies... | DRUG competitors |
| Anixa Biosciences Inc (ANIX) | Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. | ANIX competitors |
| Precision BioSciences Inc (DTIL) | Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. | DTIL competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| PDS Biotechnology Corp (PDSB) | PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. | PDSB competitors |
Frequently Asked Questions About UPB
Who are Upstream Bio's main competitors?
The companies most similar to Upstream Bio include Palisade Bio (PALI), Sutro Biopharma (STRO), Invivyd (IVVD), SAB Biotherapeutics (SABS) and Compass Therapeutics (CMPX), listed from the closest match.
Who is Upstream Bio's biggest competitor?
Precision BioSciences (DTIL) is the largest of the similar companies at $288.76M; Palisade Bio (PALI) is the closest match by business profile, size, sector and industry.
How does UPB stock compare with its competitors?
UPB's P/S is 41.0x against a peer median of 11.0x; its net margin is 0.0% against a peer median of 0.0%.
Which of Upstream Bio's competitors pays a higher dividend?
Upstream Bio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Upstream Bio bigger than its competitors?
No. Upstream Bio is 9th by market cap among the 13 companies on this page; the largest is Precision BioSciences (DTIL) at $288.76M.
UPB pages: Overview, Earnings, Forecast, Financials, Competitors